X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare GSK Pharma with AANJANEYA LIFECARE - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK PHARMA vs DR. DATSONS LABS - Comparison Results

GSK PHARMA    Change

GSK Pharma is one of the leading MNC pharma companies in the Indian market. It is a 50.7% subsidiary of GlaxoSmithKline Plc, one of the world's largest pharma companies. GSK Pharma's product portfolio boasts of some of the leading brands like Augment... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GSK PHARMA DR. DATSONS LABS GSK PHARMA/
DR. DATSONS LABS
 
P/E (TTM) x 59.2 -10.9 - View Chart
P/BV x 11.6 0.2 7,156.6% View Chart
Dividend Yield % 2.1 0.0 -  

Financials

 GSK PHARMA   DR. DATSONS LABS
EQUITY SHARE DATA
    GSK PHARMA
Mar-16
DR. DATSONS LABS
Mar-14
GSK PHARMA/
DR. DATSONS LABS
5-Yr Chart
Click to enlarge
High Rs3,850126 3,065.3%   
Low Rs2,96631 9,597.6%   
Sales per share (Unadj.) Rs332.3133.0 249.9%  
Earnings per share (Unadj.) Rs44.30.2 29,217.9%  
Cash flow per share (Unadj.) Rs47.26.6 714.7%  
Dividends per share (Unadj.) Rs50.000-  
Dividend yield (eoy) %1.50-  
Book value per share (Unadj.) Rs202.7128.8 157.4%  
Shares outstanding (eoy) m84.7031.66 267.5%   
Bonus/Rights/Conversions -FCCB-  
Price / Sales ratio x10.30.6 1,742.8%   
Avg P/E ratio x76.9516.1 14.9%  
P/CF ratio (eoy) x72.211.8 609.4%  
Price / Book Value ratio x16.80.6 2,766.6%  
Dividend payout %112.90-   
Avg Mkt Cap Rs m288,6432,477 11,651.1%   
No. of employees `0004.6NA-   
Total wages/salary Rs m4,43456 7,917.9%   
Avg. sales/employee Rs Th6,104.5NM-  
Avg. wages/employee Rs Th961.6NM-  
Avg. net profit/employee Rs Th813.7NM-  
INCOME DATA
Net Sales Rs m28,1484,211 668.5%  
Other income Rs m1,21879 1,548.0%   
Total revenues Rs m29,3664,289 684.7%   
Gross profit Rs m4,774569 839.6%  
Depreciation Rs m248204 121.3%   
Interest Rs m0430 0.0%   
Profit before tax Rs m5,74413 45,228.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m0-2 0.0%   
Extraordinary Inc (Exp) Rs m260-   
Tax Rs m2,0186 33,082.0%   
Profit after tax Rs m3,7525 78,166.7%  
Gross profit margin %17.013.5 125.6%  
Effective tax rate %35.148.0 73.1%   
Net profit margin %13.30.1 11,692.5%  
BALANCE SHEET DATA
Current assets Rs m21,4626,852 313.2%   
Current liabilities Rs m10,5366,711 157.0%   
Net working cap to sales %38.83.3 1,159.1%  
Current ratio x2.01.0 199.5%  
Inventory Days Days68161 42.1%  
Debtors Days Days16318 5.2%  
Net fixed assets Rs m4,7173,673 128.4%   
Share capital Rs m847317 267.5%   
"Free" reserves Rs m16,3083,761 433.6%   
Net worth Rs m17,1714,078 421.1%   
Long term debt Rs m161,671 1.0%   
Total assets Rs m30,62012,633 242.4%  
Interest coverage xNM1.0-  
Debt to equity ratio x00.4 0.2%  
Sales to assets ratio x0.90.3 275.8%   
Return on assets %12.33.4 355.9%  
Return on equity %21.90.1 18,561.3%  
Return on capital %33.67.7 437.5%  
Exports to sales %022.9 0.1%   
Imports to sales %15.114.3 105.3%   
Exports (fob) Rs m4964 0.4%   
Imports (cif) Rs m4,237602 703.9%   
Fx inflow Rs m519964 53.8%   
Fx outflow Rs m8,320607 1,370.4%   
Net fx Rs m-7,801357 -2,185.7%   
CASH FLOW
From Operations Rs m1,3861,345 103.0%  
From Investments Rs m5,010-2,256 -222.1%  
From Financial Activity Rs m-6,383-1,200 532.0%  
Net Cashflow Rs m12-2,111 -0.6%  

Share Holding

Indian Promoters % 0.0 4.5 -  
Foreign collaborators % 50.7 0.0 -  
Indian inst/Mut Fund % 10.2 0.0 -  
FIIs % 23.8 1.4 1,763.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 15.4 94.1 16.4%  
Shareholders   102,036 20,807 490.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GSK PHARMA With:   SHASUN PHARMA  WYETH LTD  TORRENT PHARMA  ALEMBIC LTD  DR. REDDYS LAB  

Compare GSK PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Flat Note; Dr Reddy's & Lupin Surge over 2%(Closing)

Indian share markets continued to trade just above the dotted line in the afternoon session in a lackluster day of trading. At the closing bell, the BSE Sensex closed higher by 33 points.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

GSK PHARMA SHARE PRICE


Aug 22, 2017 (Close)

TRACK GSK PHARMA

  • Track your investment in GSK PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

GSK PHARMA - TTK HEALTHCARE COMPARISON

COMPARE GSK PHARMA WITH

MARKET STATS